Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
about
Phase 1 safety assessment of intrathecal oxytocinCurrent gene therapy using viral vectors for chronic painAutism, oxytocin and interoceptionThe antinociception of oxytocin on colonic hypersensitivity in rats was mediated by inhibition of mast cell degranulation via Ca(2+)-NOS pathwayEditor's Highlight: Formulation and Toxicology Evaluation of the Intrathecal AYX1 DNA-Decoy in Sprague Dawley Rats.Ethical Concerns Regarding Human Study.
P2860
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@ast
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@en
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs.
@nl
type
label
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@ast
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@en
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs.
@nl
prefLabel
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@ast
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@en
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs.
@nl
P2093
P2860
P1433
P1476
Preclinical toxicity screening of intrathecal oxytocin in rats and dogs
@en
P2093
Christopher Peters
Kent G Osborn
Marjorie R Grafe
Philip J Richter
Shotaro Hobo
Steven S Rossi
Tony L Yaksh
P2860
P304
P356
10.1097/ALN.0000000000000148
P407
P577
2014-04-01T00:00:00Z